Abstract
Both clinical and animal studies have demonstrated that oxidative and carbonyl stress are involved in the pathogenesis of hypertension, diabetes, and chronic kidney disease (CKD). Not only does direct biochemical action cause renal injury, but oxidative/carbonyl stress also participates in the physiological role on sodium homeostasis and regulation of blood pressure. The physiological role of oxidative stress relies on the balance between nitric oxide (NO) and reactive oxygen species (ROS). The balance between NO and ROS regulates renal medullary circulation and regulates blood pressure. In physiological conditions, NO is largely produced in the tubules and diffuses into the surrounding capillaries such as the vasa recta. These NO can be counter-balanced by the ROS produced in the tubules of renal medulla such as the medullary thick ascending limb. This tubulovascular NO crosstalk in the medulla regulates medullary blood flow (MBF). Reduction of MBF with reduction of NO and increased ROS increases sodium reabsorption and thereby develops hypertension. This is one of the mechanisms of salt-sensitive hypertension seen in Dahl-salt sensitive rats. Since oxygen tension of renal medulla is flow limited, reduction of renal MBF induces hypoxia as well as ischemia. Therefore, the outer medulla is an early target for enhanced oxidative stress, such as in hypertension and diabetes. Enhanced oxidative/carbonyl stress is also involved in insulin sensitivity, which is a key pathogenesis of CKD and metabolic syndrome. An increase in renal perfusion pressure results in the enhanced expression of molecules related to oxidative stress, inflammation, and wound healing. These mechanisms had an advantage for lifestyle in ancient days but have become a silent killer in modern culture. This paradigm shift of antiaging could explain why oxidative/carbonyl stress is enhanced in modern lifestyle diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, McCullough PA, Kasiske BL, Kelepouris E, Klag MJ, Parfrey P, Pfeffer M, Raij L, Spinosa DJ, Wilson PW. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003 Nov;42(5):1050–65.
Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Snapinn SM, Wan Y, Lyle PA. Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study. Diabetes Care 2006 Mar;29(3):595–600.
Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, Gans RO, Janssen WM, Grobbee DE, de Jong PE. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 2002 Oct;106(14):1777–82.
Cubeddu LX, Hoffmann IS, Aponte LM, Nunez-Bogesits R, Medina-Suniaga H, Roa M, Garcia RS. Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens 2003 May;16(5 Pt 1):343–9.
Miyata T, Ueda Y, Yamada Y, Izuhara Y, Wada T, Jadoul M, Saito A, Kurokawa K, van Ypersele de Strihou C. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia. J Am Soc Nephrol 1998 Dec;9(12):2349–56.
Suzuki D, Miyata T, Saotome N, Horie K, Inagi R, Yasuda Y, Uchida K, Izuhara Y, Yagame M, Sakai H, Kurokawa K. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol 1999 Apr;10(4):822–32.
Miyata T, Kurokawa K, van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int Suppl 2000 Aug;76:S120–5.
Mori T, Cowley AW, Jr., Ito S. Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. J Pharmacol Sci 2006 Jan;100(1):2–8.
Nishiyama A, Yoshizumi M, Hitomi H, Kagami S, Kondo S, Miyatake A, Fukunaga M, Tamaki T, Kiyomoto H, Kohno M, Shokoji T, Kimura S, Abe Y. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. J Am Soc Nephrol 2004 Feb;15(2):306–15.
Kumagai T, Nangaku M, Kojima I, Nagai R, Ingelfinger JR, Miyata T, Fujita T, Inagi R. Glyoxalase I overexpression ameliorates renal ischemia-reperfusion injury in rats. Am J Physiol Renal Physiol 2009 Apr;296(4):F912–21.
Zou AP, Li N, Cowley AW, Jr. Production and actions of superoxide in the renal medulla. Hypertension 2001 Feb;37(2 Pt 2):547–53.
Meng S, Cason GW, Gannon AW, Racusen LC, Manning RD, Jr. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 2003 Jun;41(6):1346–52.
Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, Abe Y. Systemic and regional hemodynamic responses to tempol in angiotensin II-infused hypertensive rats. Hypertension 2001 Jan;37(1):77–83.
Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-Iso prostaglandin f2alpha. Hypertension 1999 Jan;33(1 Pt 2):424–8.
Welch WJ, Tojo A, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol 2000 May;278(5):F769–76.
Mori T, Polichnowski A, Glocka P, Kaldunski M, Ohsaki Y, Liang M, Cowley AW, Jr. High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol 2008 Aug;19(8):1472–82.
Taylor NE, Glocka P, Liang M, Cowley AW, Jr. NADPH oxidase in the renal medulla causes oxidative stress and contributes to salt-sensitive hypertension in Dahl S rats. Hypertension 2006 Apr;47(4):692–8.
Meng S, Roberts LJ, II, Cason GW, Curry TS, Manning RD, Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol Regul Integr Comp Physiol 2002 Sep;283(3):R732–8.
Cowley AW, Jr., Roman RJ, Kaldunski ML, Dumas P, Dickhout JG, Greene AS, Jacob HJ. Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat. Hypertension 2001 Feb;37(2 Pt 2):456–61.
Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW, Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension 2002 Feb;39(2 Pt 2):667–72.
Cowley AW, Jr., Stoll M, Greene AS, Kaldunski ML, Roman RJ, Tonellato PJ, Schork NJ, Dumas P, Jacob HJ. Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats. Physiol Genomics 2000 Apr;2(3):107–15.
Wu F, Park F, Cowley AW, Jr., Mattson DL. Quantification of nitric oxide synthase activity in microdissected segments of the rat kidney. Am J Physiol 1999 Jun;276(6 Pt 2):F874–81.
Tojo A, Kimoto M, Wilcox CS. Renal expression of constitutive NOS and DDAH: separate effects of salt intake and angiotensin. Kidney Int 2000 Nov;58(5):2075–83.
Ito S, Carretero OA, Abe K. Role of nitric oxide in the control of glomerular microcirculation. Clin Exp Pharmacol Physiol 1997 Aug;24(8):578–81.
Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW, Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol 1994 May;266(5 Pt 2):H1918–26.
Nakanishi K, Mattson DL, Cowley AW, Jr. Role of renal medullary blood flow in the development of l-NAME hypertension in rats. Am J Physiol 1995 Feb;268(2 Pt 2):R317–23.
Zou AP, Wu F, Cowley AW, Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. Hypertension 1998 Jan;31(1 Pt 2):271–6.
Szentivanyi M, Jr., Maeda CY, Cowley AW, Jr. Local renal medullary l-NAME infusion enhances the effect of long-term angiotensin II treatment. Hypertension 1999 Jan;33(1 Pt 2):440–5.
Cowley AW, Jr., Mori T, Mattson D, Zou AP. Role of renal NO production in the regulation of medullary blood flow. Am J Physiol Regul Integr Comp Physiol 2003 Jun;284(6):R1355–69.
Rhinehart KL, Pallone TL. Nitric oxide generation by isolated descending vasa recta. Am J Physiol Heart Circ Physiol 2001 Jul;281(1):H316–24.
Dickhout JG, Mori T, Cowley AW, Jr. Tubulovascular nitric oxide crosstalk: buffering of angiotensin II-induced medullary vasoconstriction. Circ Res 2002 Sep;91(6):487–93.
Mori T, Cowley AW, Jr. Angiotensin II-NAD(P)H oxidase-stimulated superoxide modifies tubulovascular nitric oxide cross-talk in renal outer medulla. Hypertension 2003 Oct;42(4):588–93.
Mori T, O’Connor PM, Abe M, Cowley AW, Jr. Enhanced superoxide production in renal outer medulla of Dahl salt-sensitive rats reduces nitric oxide tubular-vascular cross-talk. Hypertension 2007 Jun;49(6):1336–41.
Abe M, O’Connor P, Kaldunski M, Liang M, Roman RJ, Cowley AW, Jr. Effect of sodium delivery on superoxide and nitric oxide in the medullary thick ascending limb. Am J Physiol Renal Physiol 2006 Aug;291(2):F350–7.
Mori T, Cowley AW, Jr. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension 2004 Feb;43(2):341–6.
Chen YF, Cowley AW, Jr., Zou AP. Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 2003 Oct;285(4):R827–33.
Makino A, Skelton MM, Zou AP, Cowley AW, Jr. Increased renal medullary H2O2 leads to hypertension. Hypertension 2003 Jul;42(1):25–30.
Taylor NE, Cowley AW, Jr. Effect of renal medullary H2O2 on salt-induced hypertension and renal injury. Am J Physiol Regul Integr Comp Physiol 2005 Dec;289(6):R1573–9.
Liang M, Berndt TJ, Knox FG. Mechanism underlying diuretic effect of l-NAME at a subpressor dose. Am J Physiol Renal Physiol 2001 Sep;281(3):F414–9.
Ortiz PA, Garvin JL. Interaction of O(2)(−) and NO in the thick ascending limb. Hypertension 2002 Feb;39(2 Pt 2):591–6.
Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol 2002 Nov;283(5):F957–62.
Nakayama K, Nakayama M, Iwabuchi M, Terawaki H, Sato T, Kohno M, Ito S. Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients. Am J Nephrol 2008;28(6):871–8.
Nakayama M, Saito K, Sato E, Nakayama K, Terawaki H, Ito S, Kohno M. Radical generation by the non-enzymatic reaction of methylglyoxal and hydrogen peroxide. Redox Rep 2007;12(3):125–33.
Guo Q, Mori T, Jiang Y, Hu C, Osaki Y, Yoneki Y, Sun Y, Hosoya T, Kawamata A, Ogawa S, Nakayama M, Miyata T, Ito S. Methylglyoxal contributes to the development of insulin resistance and salt sensitivity in Sprague-Dawley rats. J Hypertens 2009 Aug;27(8):1664–71.
Endo S, Mori T, Yoneki Y, Nakamichi T, Hosoya T, Ogawa S, Tokudome G, Miyata T, Ito S. Blockade of angiotensin II type-1 receptor increases salt sensitivity in Sprague-Dawley rats. Hypertens Res 2009 Jun;32(6):513–9.
Ogawa S, Mori T, Nako K, Kato T, Takeuchi K, Ito S. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension 2006 Apr;47(4):699–705.
Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004 Aug;110(9):1103–7.
Mori T, Cowley AW, Jr. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension 2004 Apr;43(4):752–9.
Jin C, Hu C, Polichnowski A, Mori T, Skelton M, Ito S, Cowley AW, Jr. Effects of renal perfusion pressure on renal medullary hydrogen peroxide and nitric oxide production. Hypertension 2009 Jun;53(6):1048–53.
Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Halle JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001 Jul;286(4):421–6.
Ito S, Nagasawa T, Abe M, Mori T. Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk. Hypertens Res 2009 Feb;32(2):115–21.
Acknowledgments
We thank Yoshimi Yoneki, Hiroko Ito, and Kiyomi Kisu for their expert technical assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Mori, T., Miyata, T., Ito, S. (2011). Oxidative/Carbonyl Stress in the Renal Circulation and Cardiovascular Renal Injury. In: Miyata, T., Eckardt, KU., Nangaku, M. (eds) Studies on Renal Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-60761-857-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-60761-857-7_15
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-856-0
Online ISBN: 978-1-60761-857-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)